Five-year downstream outcomes following prostate-specific antigen screening in older men
about
Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision SupportProbability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.Patient-Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey.Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.Elevated hardness of peripheral gland on real-time elastography is an independent marker for high-risk prostate cancers.Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening.
P2860
Q34626043-BE5099FB-9C64-4D8F-B4F7-B171DC5EBE4BQ35876640-EE27D3A1-6B77-4DEA-8A2C-539687467A0EQ37619443-53C46C7A-F7C6-45A2-952E-6C0DF27B63DFQ40266746-0BF93E64-E6C2-4109-A4DB-19A039D957C7Q40682179-39F16E8E-1190-447B-B08D-50D6CAD1FC37Q47760304-A2DDEE64-C7EF-4004-B0CC-24BB099342AEQ55194676-08AA2CC7-1E1B-405B-9819-3F914BFBABDF
P2860
Five-year downstream outcomes following prostate-specific antigen screening in older men
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Five-year downstream outcomes following prostate-specific antigen screening in older men
@en
Five-year downstream outcomes following prostate-specific antigen screening in older men.
@nl
type
label
Five-year downstream outcomes following prostate-specific antigen screening in older men
@en
Five-year downstream outcomes following prostate-specific antigen screening in older men.
@nl
prefLabel
Five-year downstream outcomes following prostate-specific antigen screening in older men
@en
Five-year downstream outcomes following prostate-specific antigen screening in older men.
@nl
P2093
P2860
P1476
Five-year downstream outcomes following prostate-specific antigen screening in older men
@en
P2093
Adam A Powell
Kathy Z Fung
Louise C Walter
Roxanne Espaldon
Sarah O'Brien
Stephen J Freedland
P2860
P304
P356
10.1001/JAMAINTERNMED.2013.323
P577
2013-05-01T00:00:00Z